Effectiveness of Universal Precautions in Limiting Nosocomial Transmission of Hepatitis C Virus in Haemodialysis Units

Abstract

Get full access to this article

View all access options for this article.

References

Report on management of Renal Failure in Europe, XXIV, 1993.

Nephrol Dial Transpl 1995; 10: 5.

MMWR Update Universal precautions for preventing of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health care settings.

JAMA 1988; 260: 462–5.

Muller

G.Y.

, Zabeleta

M.E.

, Arminio

. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 1992; 42: 1053–8.

Calabrese

, Vagelli

, Guaschino

, Gonella

. Transmission of anti-HCV within the household of haemodialysis patients. Lancet 1991; 338: 1466.

Cuypers

H.T.M.

, Winkel

I.N.

, van der Poel

C.L.

. Analysis of genomic variability of Hepatitis C virus. J Hepatol 1991; 13: 15–9.

Garcia Valdecasas

, Bernal

C.M.

, Garcia

. Hepatitis C in hemodialysis: preventive protocol throughout 3 years. EDTA-ERA1993 Abstract Book; 970.

Jadoul

, Cornu

, van Ypersele de Strihoh

, UCL Collaborative Group. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. Kidney Int 1993; 44: 1322–6.

Fabrizi

, Lunghi

, Guarnori

. Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: a prospective study. Nephrol Dial Transpl 1994; 9: 1611–5.

Petrosillo

, Gilli

, Ippolito

. Raccomandazioni per il controllo dell'infezione da HCV in dialisi. Giorn Ital Nefrologia 1995; 5: 291–8.